News Conference News TCT 2024 ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients Todd Neale October 30, 2024
News Conference News TCT 2024 Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT Michael O'Riordan October 27, 2024
News Conference News TCT 2020 Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows Caitlin E. Cox October 14, 2020
News Conference News TCT 2018 NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days Yael L. Maxwell September 25, 2018
News Conference News TCT 2016 Transcaval TAVR Presents New Option for Patients With Complex Anatomy Yael L. Maxwell October 29, 2016
Presentation TCT 2013 TAVR Migration from Inoperable to Moderate Risk Patients: Practice and Caveats Presenter: Christian Hamm October 29, 2013
Presentation TCT 2012 Case Selection Caveats from the U.S. CoreValve Pivotal Clinical Trial Presenter: Jeffrey Popma October 22, 2012